rdf:type |
|
lifeskim:mentions |
umls-concept:C0020792,
umls-concept:C0036825,
umls-concept:C0205263,
umls-concept:C0229671,
umls-concept:C0246415,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0574032,
umls-concept:C0879626,
umls-concept:C1171362,
umls-concept:C1537055,
umls-concept:C1552599,
umls-concept:C1563699,
umls-concept:C1704787,
umls-concept:C1979963,
umls-concept:C2003903
|
pubmed:issue |
2B
|
pubmed:dateCreated |
2005-5-3
|
pubmed:abstractText |
For the development of quick and easy methods for screening and identifying treatment-responsive proteins, we determined the protein expression profile of the serum after docetaxel infusion using a surface-enhanced laser desorption/ionization time-of-flight mass spectroscopy (SELDI TOF-MS) system. Materials and
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author |
pubmed-author:AogiKenjiroK,
pubmed-author:ArikuniHisashiH,
pubmed-author:EguchiKenjiK,
pubmed-author:FujiiDaisukeD,
pubmed-author:HeikeYujiY,
pubmed-author:HosokawaMamiM,
pubmed-author:IdaMikikoM,
pubmed-author:OsumiShozoS,
pubmed-author:ShiwaMiekoM,
pubmed-author:TajiriHisaoH,
pubmed-author:TakashimaShigemitsuS,
pubmed-author:TakaueYoichiY,
pubmed-author:TakigawaNagioN,
pubmed-author:WakatabeRumiR
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1197-203
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15865066-Amino Acid Sequence,
pubmed-meshheading:15865066-Biological Markers,
pubmed-meshheading:15865066-Blood Proteins,
pubmed-meshheading:15865066-Breast Neoplasms,
pubmed-meshheading:15865066-Female,
pubmed-meshheading:15865066-Humans,
pubmed-meshheading:15865066-Protein Array Analysis,
pubmed-meshheading:15865066-Spectrometry, Mass, Matrix-Assisted Laser...,
pubmed-meshheading:15865066-Taxoids
|
pubmed:articleTitle |
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip system.
|
pubmed:affiliation |
Department of Medical Oncology and Clinical Research, National Shikoku Cancer Center, Matsuyama, Ehime 790-0007, Japan. yheike@ncc.go.jp
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|